Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Correlation of CGS 19755 neuroprotection against in vitro excitotoxicity and focal cerebral ischemia.
J Cereb Blood Flow Metab. 1995 Sep;15(5):865-76. doi: 10.1038/jcbfm.1995.108.
J Cereb Blood Flow Metab. 1995.
PMID: 7673380
CSF and brain levels of CGS 19755 were 12 microM and 5 microM, respectively, at 1 h, 6 microM and 5 microM at 2 h, and 13 microM and 7 microM at 4 h. ...
CSF and brain levels of CGS 19755 were 12 microM and 5 microM, respectively, at 1 h, 6 microM and 5 microM at 2 h, and 13 microM and …
Neuroprotection by the N-methyl-D-aspartate receptor antagonist CGP 40116: in vivo and in vitro studies.
Maier CM, Sun GH, Kunis DM, Giffard RG, Steinberg GK.
Maier CM, et al.
J Neurochem. 1995 Aug;65(2):652-9. doi: 10.1046/j.1471-4159.1995.65020652.x.
J Neurochem. 1995.
PMID: 7616221
CGP 40116 decreased cortical ischemic neuronal damage by 74 and 77% (control, 37.8 +/- 13.1%; CGP 20 mg/kg, 9.9 +/- 3.6%; CGP 40 mg/kg, 8.7 +/- 3.7%; p < 0.01) and reduced cortical ischemic edema by 52 and 35% (control, 42.3 +/- 10.4%; CGP 20 mg/kg, 20.1 +/- 6.7%
…
CGP 40116 decreased cortical ischemic neuronal damage by 74 and 77% (control, 37.8 +/- 13.1%; CGP 20 mg/kg, 9.9 +/- 3.6%; CGP 40 mg/k …
Item in Clipboard
Cite
Cite